ATE454467T1 - Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen - Google Patents

Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen

Info

Publication number
ATE454467T1
ATE454467T1 AT02710865T AT02710865T ATE454467T1 AT E454467 T1 ATE454467 T1 AT E454467T1 AT 02710865 T AT02710865 T AT 02710865T AT 02710865 T AT02710865 T AT 02710865T AT E454467 T1 ATE454467 T1 AT E454467T1
Authority
AT
Austria
Prior art keywords
transcription
cells
expression products
cancerical
treating
Prior art date
Application number
AT02710865T
Other languages
English (en)
Inventor
Garcia Isidro Sanchez
De Matos Alberto Orfao
Losada Jesus Perez
Original Assignee
Univ De Salamanca O T R I
Consejo Superior Investigacion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ De Salamanca O T R I, Consejo Superior Investigacion filed Critical Univ De Salamanca O T R I
Application granted granted Critical
Publication of ATE454467T1 publication Critical patent/ATE454467T1/de

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/5751Immunoassay; Biospecific binding assay; Materials therefor for cancer of the skin, e.g. melanoma
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/575Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57505Immunoassay; Biospecific binding assay; Materials therefor for cancer of the blood, e.g. leukaemia
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/158Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Pathology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Wood Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT02710865T 2001-01-23 2002-01-23 Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen ATE454467T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ES200100151A ES2185472B1 (es) 2001-01-23 2001-01-23 Empleo del gen slug, o de sus productos de transcripcion o expresion, en la deteccion y/o tratamiento de celulas cancerosas.
PCT/ES2002/000026 WO2002059361A1 (es) 2001-01-23 2002-01-23 Empleo del gen slug o de sus productos de transcripcion o expresion en la deteccion y/o tratamiento de celulas cancerosas

Publications (1)

Publication Number Publication Date
ATE454467T1 true ATE454467T1 (de) 2010-01-15

Family

ID=8496481

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02710865T ATE454467T1 (de) 2001-01-23 2002-01-23 Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen

Country Status (7)

Country Link
US (1) US7776519B2 (de)
EP (1) EP1354962B1 (de)
JP (1) JP2004520045A (de)
AT (1) ATE454467T1 (de)
DE (1) DE60234991D1 (de)
ES (4) ES2185472B1 (de)
WO (1) WO2002059361A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2195751B1 (es) 2001-11-27 2005-04-01 Universidad De Salamanca (Otri) Mamiferos no humanos transgenicos como modelos para patologias humanas con origen en celulas stem.
ES2253028B1 (es) * 2003-05-30 2007-08-01 Universidad De Salamanca "empleo del gen slug, sus productos de transcripcion o expresion, y/o compuestos inhibidores o estimuladores de la expresion de slug para conferir radioresistencia o radioproteccion celular.
ES2301268B1 (es) * 2004-10-25 2009-05-01 Centro De Investigacion Biomolecular Aplicada Salamanca, S.L. Empleo del gen slug, o de sus productos de replicacion, transcripcion o expresion, en la identificacion, diagnostico, prevencion o tratamiento de la diseminacion del cancer y/o desarrollo de metastasis.
CA2656548A1 (en) * 2005-06-30 2007-01-11 Whitehead Institute Progenitor cells and uses thereof
US20110302665A1 (en) * 2008-07-02 2011-12-08 Oktay Kirak Non-human mammals with t or b cells having predefined specificity
KR101805181B1 (ko) 2016-09-02 2017-12-07 충북대학교 산학협력단 인산화된 slug 단백질의 유사분열 세포에 대한 신규한 바이오 마커로서의 용도
EP4457341A1 (de) * 2021-12-30 2024-11-06 Mestastop Solutions Private Limited Verfahren zur herstellung eines spontanen metastasemodells
CN116747309B (zh) * 2023-06-20 2025-12-05 中山大学 Slug抑制剂在制备华支睾吸虫细胞外囊泡诱导的胆管癌的治疗药物中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4965188A (en) 1986-08-22 1990-10-23 Cetus Corporation Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4683195A (en) 1986-01-30 1987-07-28 Cetus Corporation Process for amplifying, detecting, and/or-cloning nucleic acid sequences
EP2481814A3 (de) * 2003-06-09 2012-10-10 The Regents of the University of Michigan Zusammensetzungen und Verfahren zur Behandlung und Diagnose von Krebs

Also Published As

Publication number Publication date
JP2004520045A (ja) 2004-07-08
ES2242469A1 (es) 2005-11-01
DE60234991D1 (de) 2010-02-25
ES2185472A1 (es) 2003-04-16
ES2339335T3 (es) 2010-05-19
ES2185472B1 (es) 2004-10-16
ES2242469B1 (es) 2006-07-16
EP1354962A1 (de) 2003-10-22
EP1354962B1 (de) 2010-01-06
ES2241402B1 (es) 2007-02-16
US20060141454A1 (en) 2006-06-29
US7776519B2 (en) 2010-08-17
ES2241402A1 (es) 2005-10-16
WO2002059361A1 (es) 2002-08-01

Similar Documents

Publication Publication Date Title
ATE454468T1 (de) Nachweis der instabilität von mikrosatelliten und verwendung davon bei der tumordiagnose
NZ593289A (en) Anti-neuropilin-1 antibodies for treating angiogenesis
DE69503129D1 (de) Pteridin-nukleotidderivate als fluoreszierende sonden
ATE337011T1 (de) Modifizierte psma-liganden und deren verwendung
PT991421E (pt) Deteccao e modulacao das iap e naip para o diagnostico e tratamento de doenca proliferativa
WO2005084109A3 (en) Cancer specific gene mh15
NO20024240D0 (no) Nye arylfruktose-1,6-bisfosfataseinhibitorer
AU2003293141A8 (en) Methods for identifying risk of breast cancer and treatments thereof
DE60234991D1 (de) Verwendung des slug-gens oder der transkriptions- oder expressionsprodukte davon beim nachweis und/oder bei der behandlung von krebsartigen zellen
WO2002022879A3 (en) Detection of microsatellite instability and its use in diagnosis of tumors
DE602004015626D1 (de) Bei brustkrebs
WO2003025141A3 (en) Genetic analysis for stratification of cancer risk
DE60027045D1 (de) Oligonukleotide und diese enthaltende komplexe zur detektion der anwesenheit oder abwesenheit einer zielnukleinsäure in einer probe
WO2002031209A3 (en) Genes related to development of refractory prostate cancer
AU2003264078A8 (en) Method for analyzing body fluids for the presence of cancer cells, use thereof, corresponding analysis kits, and use of specific active substances for treating cancer
MXPA05014220A (es) Genes regulados en cancer ovarico como objetivos de pronostico y terapeuticos.
ATE531529T1 (de) Wertdokument, herstellung und prüfung von wertdokumenten
WO2005014846A3 (en) Methods for identifying risk of breast cancer and treatments thereof
ATE229571T1 (de) Nachweis und identifizierung von nicht-polio enteroviren
WO2003030725A3 (en) Pancreatic cancer diagnosis and therapies
WO2005024067A3 (en) Genetic analysis for stratification of breast cancer risk
ATE333521T1 (de) Detektion von vancomycin-resistenten enterococcus-subspezies
WO2003062826A3 (en) Materials and methods for examining and treating nasopharyngeal carcinoma
WO2002044419A3 (en) Expression analysis of kiaa nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
WO2004048546A3 (en) Methods for identifying risk of breast cancer and treatments thereof

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties